Silverman K, Evans S M, Strain E C, Griffiths R R
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224.
N Engl J Med. 1992 Oct 15;327(16):1109-14. doi: 10.1056/NEJM199210153271601.
People who stop consuming caffeine may have symptoms, but the incidence and severity of caffeine withdrawal are not known. This study was performed to determine the effects in the general population of ending one's dietary intake of caffeine.
We studied 62 normal adults whose intake of caffeine was low to moderate (mean amount, 235 mg--the equivalent of 2.5 cups of coffee--per day). They completed questionnaires about symptoms and tests of their mood and performance when consuming their normal diets (base-line period) and at the end of each of two two-day periods during which they consumed caffeine-free diets and under double-blind conditions received capsules containing placebo (placebo period) or caffeine (caffeine period) in amounts equal to their daily caffeine consumption.
More subjects had abnormally high Beck Depression Inventory scores (11 percent), high scores on the trait scale of the State-Trait Anxiety Inventory (8 percent), low vigor scores (11 percent) and high fatigue scores (8 percent) on the Profile of Mood States, and moderate or severe headache (52 percent) during the placebo period than during either the base-line period (2, 0, 0, 0, and 2 percent, respectively; P less than 0.05) or the caffeine period (3, 2, 2, 0, and 6 percent; P less than 0.05). More subjects reported unauthorized use of medications during the placebo period (13 percent) than during the caffeine period (2 percent, P = 0.017). Performance of a tapping task was slower during the placebo period than during the base-line and caffeine periods (P less than 0.01).
Persons who consume low or moderate amounts of caffeine may have a withdrawal syndrome after their daily consumption of caffeine ceases.
停止摄入咖啡因的人可能会出现症状,但咖啡因戒断的发生率和严重程度尚不清楚。本研究旨在确定停止饮食中咖啡因摄入对普通人群的影响。
我们研究了62名正常成年人,他们的咖啡因摄入量低至中等(平均量为每天235毫克,相当于2.5杯咖啡)。他们完成了关于症状的问卷,并在食用正常饮食时(基线期)以及在两个为期两天的时间段结束时进行了情绪和表现测试,在这两个时间段内,他们食用无咖啡因饮食,并在双盲条件下接受含有安慰剂(安慰剂期)或咖啡因(咖啡因期)的胶囊,其含量等于他们的每日咖啡因摄入量。
与基线期(分别为2%、0%、0%、0%和2%;P<0.05)或咖啡因期(3%、2%、2%、0%和6%;P<0.05)相比,更多的受试者在安慰剂期出现贝克抑郁量表得分异常高(11%)、状态-特质焦虑量表特质量表得分高(8%)、情绪状态剖面图活力得分低(11%)和疲劳得分高(8%),以及中度或重度头痛(52%)。与咖啡因期(2%,P=0.017)相比,更多的受试者在安慰剂期报告未经授权使用药物(13%)。在安慰剂期进行敲击任务的表现比基线期和咖啡因期慢(P<0.01)。
摄入低或中等量咖啡因的人在停止每日咖啡因摄入后可能会出现戒断综合征。